Results from on-going EMPA-KIDNEY (NCT03594110), DELIVER (NCT0319213), SMARTEST (NCT03982381), as well as the recently terminated SCORED (NCT03315143) and SOLOIST-WHF (NCT03521934) trials will further elucidate the cardioprotective effects and identify patients who may benefit most from treatment with SGLT2 inhibitors
Lipo C is prescribed off-label by licensed providers as adjunctive therapy for metabolic support, not as a primary weight loss treatment
C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies
Because people often switch jobs and health insurers, there isnt always an incentive to pay upfront for a drug that may generate health benefits and cost reductions in the future, said Larry Levitt, executive vice president at the health policy think tank KFF
Ozempic is a prescription medication with FDA approval for managing blood sugar levels in people with type 2 diabetes
Taking ibuprofen on an empty stomach while managing tirzepatide-induced nausea increases gastritis risk significantly